These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1864823)

  • 1. Management of thalassemia major (Cooley's anemia).
    Piomelli S; Loew T
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):557-69. PubMed ID: 1864823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of Cooley's anemia.
    Nathan DG
    Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeuetic management of patients with thalassemia major].
    Thuret I
    Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of patients with Cooley's anemia: transfusions and splenectomy.
    Piomelli S
    Semin Hematol; 1995 Oct; 32(4):262-8. PubMed ID: 8560283
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with therapy in Cooley's anaemia.
    Vullo C; Di Palma A
    Prog Clin Biol Res; 1989; 309():43-9. PubMed ID: 2780749
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalassemia: the facts and the controversies.
    Catlin AJ
    Pediatr Nurs; 2003; 29(6):447-9, 451. PubMed ID: 14743841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Cooley's anaemia.
    Piomelli S
    Baillieres Clin Haematol; 1993 Mar; 6(1):287-98. PubMed ID: 8353315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of thalassemia].
    Terzoli S; Fontanelli G; Carnelli V
    Pediatr Med Chir; 1984; 6(6):753-4. PubMed ID: 6545584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N; Tortarolo M; Volpe E; Gonnella F; Valente A; Buonanno G
    Haematologica; 1981 Apr; 66(2):196-207. PubMed ID: 6791996
    [No Abstract]   [Full Text] [Related]  

  • 13. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Ault P; Jones K
    Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Cooley's anemia].
    Bonduel A
    Arch Argent Pediatr; 1971 Aug; 69(6):238-9. PubMed ID: 5121587
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670).
    Di Tucci AA; Murru R; Alberti D; Rabault B; Deplano S; Angelucci E
    Eur J Haematol; 2007 Jun; 78(6):540-2. PubMed ID: 17391307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.